Connect with us
Gilead Sciences focuses on developing treatments for HIV, cancer, and inflammatory diseases, driven by blockbuster drugs like Biktarvy. Growth relies on innovation, patents, and acquisitions. While...
PCSK9 inhibitors have transformed LDL cholesterol management in familial hypercholesterolemia, with new antibodies and CETP inhibitors like obicetrapib expanding options. Statins remain safe and effective, achieving...
Bristol Myers Squibb announced NHS funding for CAR-T therapy Breyanzi, enabling its use from April 1st in Spain for lymphoma treatment. It targets several aggressive subtypes...
SPECT-CT is a key cardiac imaging technique that evaluates blood flow to heart muscle, identifying reduced perfusion and prior damage. Conducted in stress and rest phases,...
Italy’s pharmaceutical sector invests €4 billion annually, including €2.3 billion in R&D and €1.7 billion in industrial technologies, up 21% in five years. Strong university collaboration...
EU Commissioner Olivér Várhelyi proposed a Biotechnology Law to boost competitiveness, cut clinical trial times, and reduce fragmentation. Measures include streamlined regulations, AI-driven research acceleration, and...
Eli Lilly warns that compounded tirzepatide mixed with vitamin B12 may form harmful impurities with unknown health effects. These untested combinations lack safety data and regulatory...
The GEMINI study shows AI can transform breast cancer screening by increasing detection rates by 10.4% while reducing radiologists’ workload by up to 31%. Using the...
Novo Nordisk A/S (ISIN: DK0062498333) is a stable, growth-oriented biotech stock in 2026, driven by blockbuster drugs Ozempic and Wegovy. Dominating the diabetes and obesity markets,...
Evotec SE remains in focus after a turbulent year marked by a profit warning, cyberattack, and leadership change. The Hamburg-based biotech partner works with firms like...
 |
|
 |  |
 |
|